Literature DB >> 12527333

beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

Manuela Bartolini1, Carlo Bertucci, Vanni Cavrini, Vincenza Andrisano.   

Abstract

The aggregation of beta-amyloid (1-40) (Abeta) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of circular dichroism (CD) and by thioflavin T fluorescence spectroscopy. Abeta was incubated alone and with HuAChE. The kinetic of fibrils formation was followed for 48 hr. The increasing beta-conformation content induced by HuAChE, preliminary to the formation of Abeta fibrils, was determined by circular dichroism. This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm. Incubation experiments were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Abeta aggregation. The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature. At 100 microM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Abeta aggregation by 82, 25, 22 and 30%, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527333     DOI: 10.1016/s0006-2952(02)01514-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  70 in total

1.  Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

Authors:  M Dumont; R Lalonde; J-F Ghersi-Egea; K Fukuchi; C Strazielle
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics.

Authors:  Yechun Xu; Jacques-Philippe Colletier; Martin Weik; Hualiang Jiang; John Moult; Israel Silman; Joel L Sussman
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

3.  Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes.

Authors:  R R Kaizer; M C Corrêa; L R S Gris; C S da Rosa; D Bohrer; V M Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-05-10       Impact factor: 3.996

4.  Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.

Authors:  William Horton; Abha Sood; Swarada Peerannawar; Nandor Kugyela; Aditya Kulkarni; Rekha Tulsan; Chris D Tran; Jessica Soule; Harry LeVine; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2016-11-24       Impact factor: 2.823

5.  Butyrylcholinesterase attenuates amyloid fibril formation in vitro.

Authors:  Sophia Diamant; Erez Podoly; Assaf Friedler; Hagai Ligumsky; Oded Livnah; Hermona Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

6.  Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.

Authors:  Marina Naldi; Jessica Fiori; Marco Pistolozzi; Alex F Drake; Carlo Bertucci; Rongliang Wu; Krzysztof Mlynarczyk; Slawomir Filipek; Angela De Simone; Vincenza Andrisano
Journal:  ACS Chem Neurosci       Date:  2012-09-04       Impact factor: 4.418

7.  Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.

Authors:  Pran Kishore Deb; Anuradha Sharma; Poonam Piplani; Raghuram Rao Akkinepally
Journal:  Mol Divers       Date:  2012-09-21       Impact factor: 2.943

Review 8.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

9.  Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions.

Authors:  Gabrielle L Haddad; Sherri C Young; Ned D Heindel; Darryl J Bornhop; Robert A Flowers
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-04       Impact factor: 15.336

Review 10.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.